A ‘revolutionary’ drug trial aimed at discovering personalised treatments for the UK’s biggest cancer killer will begin in July, in an advance which experts say opens up a ‘new era’ in the fight against cancer. [s]The Independent[/s] reports that in an ‘unprecedented’ partnership between cancer researchers, the [b]NHS[/b] and the pharmaceutical industry, scientists will exploit a new understanding of the genetic properties of cancer tumours to help them identify drugs to be ‘targeted’ at patients with specific variants of lung cancer. Scientists at [b]Cancer Research UK[/b], who have spearheaded the ‘genetic revolution’ in cancer treatment, will be granted special access to the drugs libraries of pharmaceutical giants [b]AstraZeneca[/b] and [b]Pfizer[/b].
[link url=http://www.independent.co.uk/life-style/health-and-families/health-news/revolutionary-genetic-drug-trial-will-open-up-a-new-era-in-the-fight-against-cancer-9265483.html]Full report in The Independent[/link]